Literature DB >> 6692597

Liver cell surface expression of the antigen reacting with liver-kidney microsomal antibody (LKM).

M Lenzi, F B Bianchi, F Cassani, E Pisi.   

Abstract

To test the hypothesis that liver membrane antibodies, found in all liver-kidney microsomal antibody (LKM) positive sera from patients with chronic active hepatitis, were directed against antigens shared by both hepatocellular endoplasmic reticulum and plasma membranes, absorption experiments have been performed using viable isolated hepatocytes and liver microsomes as antigens. Results are in agreement with the above hypothesis, LKM, which displays a restricted organ specificity, is thus able to react with antigenic determinants expressed on the liver cell surface, as it has been demonstrated for strictly organ specific antibodies directed against thyroid, adrenal and gastric parietal cell microsomes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6692597      PMCID: PMC1535786     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Microsomal antibodies in active chronic hepatitis and other disorders.

Authors:  M Rizzetto; G Swana; D Doniach
Journal:  Clin Exp Immunol       Date:  1973-11       Impact factor: 4.330

3.  Occurrence and significance of IgG liver membrane autoantibodies (LMA) in chronic liver diseases of different aetiology.

Authors:  R Meliconi; M V Stancari; M Garagnani; M Baraldini; G F Stefanini; F Miglio; G Gasbarrini
Journal:  Clin Exp Immunol       Date:  1983-03       Impact factor: 4.330

4.  Gastric parietal cell antibodies: demonstration by immunofluorescence of their reactivity with surface of the gastric parietal cells.

Authors:  C Masala; G Smurra; M A Di Prima; M A Amendolea; D Celestino; F Salsano
Journal:  Clin Exp Immunol       Date:  1980-08       Impact factor: 4.330

5.  HBsAg-induced hypertrophic smooth endoplasmic reticulum as a target for liver-kidney microsomal (LKM) antibodies.

Authors:  G Ballardini; P Landi; C A Busachi; F B Bianchi; E Pisi
Journal:  Clin Exp Immunol       Date:  1981-03       Impact factor: 4.330

6.  Clinical relevance of liver membrane antibody in chronic liver disease of children.

Authors:  C Wolfrom; D Frommel
Journal:  Clin Immunol Immunopathol       Date:  1983-02

7.  A microELISA assay to detect anti-liver-specific protein antibodies in the sera of patients with liver diseases.

Authors:  M Lenzi; F Cassani; F B Bianchi; C Franceschi
Journal:  J Immunol Methods       Date:  1983-02-25       Impact factor: 2.303

8.  Presence of the organ-specific 'microsomal' autoantigen on the surface of human thyroid cells in culture: its involvement in complement-mediated cytotoxicity.

Authors:  E L Khoury; L Hammond; G F Bottazzo; D Doniach
Journal:  Clin Exp Immunol       Date:  1981-08       Impact factor: 4.330

9.  Controlled proteolysis of nascent polypeptides in rat liver cell fractions. I. Location of the polypeptides within ribosomes.

Authors:  G Blobel; D D Sabatini
Journal:  J Cell Biol       Date:  1970-04       Impact factor: 10.539

10.  Antibodies to normal human melanocytes in vitiligo.

Authors:  G K Naughton; M Eisinger; J C Bystryn
Journal:  J Exp Med       Date:  1983-07-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Xenobiotic-metabolizing enzymes as autoantigens in human autoimmune disorders. An update.

Authors:  E Boitier; P Beaune
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

2.  Precipitating antibodies to rabbit thymus extractable antigens in chronic liver disease: relationship with anti-actin antibodies.

Authors:  F Cassani; M Fusconi; F B Bianchi; L Selleri; L Baffoni; M Lenzi; E Pisi
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

3.  Type II autoimmune hepatitis: the conundrum of cytochrome P450IID6.

Authors:  D Vergani; G Mieli-Vergani
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

4.  Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane.

Authors:  L Muratori; M Parola; A Ripalti; G Robino; P Muratori; G Bellomo; R Carini; M Lenzi; M P Landini; E Albano; F B Bianchi
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

5.  Cytochrome P450IID6 recognized by LKM1 antibody is not exposed on the surface of hepatocytes.

Authors:  A M Yamamoto; C Mura; C De Lemos-Chiarandini; R Krishnamoorthy; F Alvarez
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

6.  A diagnostic marker of autoimmune chronic active hepatitis: liver plasma membrane antibody in the serum absorbed with particulate fraction of kidney homogenate.

Authors:  G Toda; Y Ikeda; N Hashimoto; T Maruyama; H Oka
Journal:  Gastroenterol Jpn       Date:  1987-06

7.  Characterization of anti-liver kidney microsomal antibody in childhood autoimmune chronic active hepatitis: evidence for IgG1 subclass restriction, polyclonality and non cross-reactivity with hepatocyte surface antigens.

Authors:  M Peakman; A Lobo-Yeo; G Mieli-Vergani; E T Davies; A P Mowat; D Vergani
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.